5,312 Shares in iShares U.S. Pharmaceuticals ETF $IHE Bought by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,312 shares of the company’s stock, valued at approximately $534,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE boosted its stake in iShares U.S. Pharmaceuticals ETF by 2.8% during the 1st quarter. Bank of America Corp DE now owns 456,606 shares of the company’s stock valued at $39,579,000 after purchasing an additional 12,565 shares in the last quarter. MinichMacGregor Wealth Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth $32,098,000. Insight Wealth Strategies LLC raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 3.3% in the 2nd quarter. Insight Wealth Strategies LLC now owns 122,642 shares of the company’s stock worth $12,055,000 after buying an additional 3,950 shares in the last quarter. Cetera Investment Advisers raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 675.4% in the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after buying an additional 95,353 shares in the last quarter. Finally, Virtue Capital Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter valued at $6,239,000.

iShares U.S. Pharmaceuticals ETF Stock Up 1.0%

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $106.60 on Friday. The business has a fifty day simple moving average of $102.48 and a 200-day simple moving average of $95.27. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $75.03 and a fifty-two week high of $110.44. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of 17.75 and a beta of 0.47.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.